glp-1 als Science's 2023 Breakthrough: GLP-1R Agonists The GLP-1 receptor agonist, liraglutide,

Obesity (Silver Spring) 2022;30(11):21112121

When microdosing is used within a structured medical program it can support subtle refinements improved adherence and steadier energy

Safety Considerations: GLP-1 Medications and Alcohol Use Understanding the safety profile of GLP-1 receptor agonists in the context of alcohol consumption is essential for both patients and healthcare professionals

Elkind-Hirsch et al

Acknowledgements The authors thank the following funding sources: NIDA and NIAAA Intramural Research Programs (L.L

The average medical school provides limited nutrition education throughout a students four years, and nutrition-related competencies are often absent from most medical specialties in graduate medical education